Familial hypercholesterolaemia: cholesterol efflux and coronary disease

Apolipoprotein M in lipid metabolism and cardiometabolic diseases

(2015) Anna Borup et al.   CURRENT OPINION IN LIPIDOLOGY

Association of HDL cholesterol efflux capacity with incident coronary heart disease events: a prospective case-control study

(2015) Danish Saleheen et al.   Lancet Diabetes & Endocrinology

Gestational diabetes mellitus modulates neonatal high-density lipoprotein composition and its functional heterogeneity

(2014) Ivana Sreckovic et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS

Humans With Atherosclerosis Have Impaired ABCA1 Cholesterol Efflux and Enhanced High-Density Lipoprotein Oxidation by Myeloperoxidase

(2014) Baohai Shao et al.   CIRCULATION RESEARCH

HDL Cholesterol Efflux Capacity and Incident Cardiovascular Events

(2014) Anand Rohatgi et al.   NEW ENGLAND JOURNAL OF MEDICINE

Paradoxical Association of Enhanced Cholesterol Efflux With Increased Incident Cardiovascular Risks

(2013) Xin-Min Li et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Vascular effects and safety of dalcetrapib in patients with or at risk of coronary heart disease: the dal-VESSEL randomized clinical trial

(2012) Thomas F. Lüscher et al.   EUROPEAN HEART JOURNAL

High-density lipoprotein subclasses and their relationship to cardiovascular disease

(2012) H. Robert Superko et al.   Journal of Clinical Lipidology

Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study

(2012) Benjamin F Voight et al.   LANCET

Atheroprotective Reverse Cholesterol Transport Pathway Is Defective in Familial Hypercholesterolemia

(2011) Natacha Bellanger et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Predictive value of different HDL particles for the protection against or risk of coronary heart disease

(2011) Kerry-Anne Rye et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS

ABCA1, ABCG1, and SR-BI: Transit of HDL-associated sphingosine-1-phosphate

(2011) Xing Liu et al.   CLINICA CHIMICA ACTA

Mechanism of cholesterol efflux in humans after infusion of reconstituted high-density lipoprotein

(2011) Anh Hoang et al.   EUROPEAN HEART JOURNAL

S1P, dihydro-S1P and C24:1-ceramide levels in the HDL-containing fraction of serum inversely correlate with occurrence of ischemic heart disease

(2011) Kelley M Argraves et al.   Lipids in Health and Disease

Genetic Variant of the Scavenger Receptor BI in Humans

(2011) Menno Vergeer et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and Atherosclerosis

(2011) Amit V. Khera et al.   NEW ENGLAND JOURNAL OF MEDICINE

Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy

(2011)   NEW ENGLAND JOURNAL OF MEDICINE

Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M

(2011) C. Christoffersen et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

High-Density Lipoprotein and Coronary Heart Disease

(2010) Pradeep Natarajan et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Export and functions of sphingosine-1-phosphate

(2009) Roger H. Kim et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS

Sphingosine-1-phosphate as a mediator of high-density lipoprotein effects in cardiovascular protection

(2009) K. Sattler et al.   CARDIOVASCULAR RESEARCH

Macrophage cholesterol efflux correlates with lipoprotein subclass distribution and risk of obstructive coronary artery disease in patients undergoing coronary angiography

(2009) Patrick Linsel-Nitschke et al.   Lipids in Health and Disease

HDL is the major lipoprotein carrier of plasma F2-isoprostanes

(2008) Julie M. Proudfoot et al.   JOURNAL OF LIPID RESEARCH

A GENETIC VARIANT OF APOLIPOPROTEIN M INCREASES SUSCEPTIBILITY TO CORONARY ARTERY DISEASE IN A CHINESE POPULATION

(2007) Wei-Wei Xu et al.   CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY